World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
41718
World Ranking
10321
National Ranking
5308

Overview

Bob S. Carter is affiliated with Harvard University in the United States. Their research spans multiple areas within medicine, biochemistry, genetics, and molecular biology, with a strong focus on neurological and oncological fields. They have produced a significant body of work in molecular biology, genetics, neurology, cancer research, and oncology.

Carter's work covers a variety of specialized topics, including:

  • Glioma Diagnosis and Treatment
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • CAR-T cell therapy research
  • Nanoplatforms for cancer theranostics
  • Cancer Genomics and Diagnostics
  • Single-cell and spatial transcriptomics

The scientist's frequent publication venues reflect their interdisciplinary expertise, with numerous contributions in:

  • Neurosurgery
  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of neurosurgery
  • Cancers

Bob S. Carter has collaborated extensively with several colleagues, most frequently with Leonora Balaj, William T. Curry, Brian V. Nahed, Daniel P. Cahill, and Anudeep Yekula.

Some of the notable recent papers authored by Carter include:

  • "Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease," 2020, New England Journal of Medicine
  • "Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies," 2020, International Forum of Allergy & Rhinology
  • "Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma," 2024, New England Journal of Medicine
  • "Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression," 2022, Nature Immunology
  • "An integrated magneto-electrochemical device for the rapid profiling of tumour extracellular vesicles from blood plasma," 2021, Nature Biomedical Engineering

Best Publications

  • An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Cyril Neftel;Julie Laffy;Mariella G. Filbin;Toshiro Hara

  • Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.

    Johnny C. Akers;David Gonda;Ryan Kim;Bob S. Carter

  • Family history and the risk of prostate cancer.

    Gary D. Steinberg;Bob S. Carter;Terri H. Beaty;Barton Childs

  • Mendelian inheritance of familial prostate cancer.

    Bob S. Carter;Terri H. Beaty;Gary D. Steinberg;Barton Childs

  • Hereditary Prostate Cancer: Epidemiologic and Clinical Features

    Bob S. Carter;G. Steven Bova;Terri H. Beaty;Gary D. Steinberg

  • Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

    Umbas R;Schalken Ja;Aalders Tw;Carter Bs

  • Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

    Huilin Shao;Jaehoon Chung;Leonora Balaj;Alain Charest

  • Allelic loss of chromosomes 16q and 10q in human prostate cancer.

    B S Carter;C M Ewing;W S Ward;B F Treiger

  • Sexual function following radical prostatectomy : influence of preservation of neurovascular bundles

    David M. Quinlan;Jonathan I. Epstein;Bob S. Carter;Patrick C. Walsh

  • Microfluidic isolation and transcriptome analysis of serum microvesicles

    Chihchen Chen;Johan Skog;Chia-Hsien Hsu;Ryan T. Lessard

  • Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

    William B. Isaacs;Bob S. Carter;Charles M. Ewing

  • Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

    Eelco F. M. Wijdicks;Kevin N. Sheth;Bob S. Carter;David M. Greer

  • Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.

    Huilin Shao;Jaehoon Chung;Jaehoon Chung;Kyungheon Lee;Leonora Balaj

  • CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

    Bryan D Choi;Xiaoling Yu;Ana P Castano;Amanda A Bouffard

  • Homozygous Deletion and Frequent Allelic Loss of Chromosome 8p22 Loci in Human Prostate Cancer

    G S Bova;B S Carter;B S Carter;B S Carter;M J Bussemakers;M Emi

  • Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles

    Franz L. Ricklefs;Franz L. Ricklefs;Quazim Alayo;Harald Krenzlin;Ahmad B. Mahmoud;Ahmad B. Mahmoud

  • Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.

    Manish K. Aghi;Bob S. Carter;Garth R. Cosgrove;Robert G. Ojemann

  • Coding and noncoding landscape of extracellular RNA released by human glioma stem cells

    Zhiyun Wei;Arsen O. Batagov;Sergio Schinelli;Jintu Wang

  • One-year Outcome after Decompressive Surgery for Massive Nondominant Hemispheric Infarction

    Bob S. Carter;Christopher S. Ogilvy;Guillermo J. Candia;H. Diana Rosas

  • Androgen receptor gene mutations in human prostate cancer.

    Jay R. Newmark;Dianne O. Hardy;Dalal C. Tonb;Bob S. Carter

Frequent Co-Authors

Christopher S. Ogilvy
Christopher S. Ogilvy Beth Israel Deaconess Medical Center
Fred G. Barker
Fred G. Barker Harvard University
Fred H. Hochberg
Fred H. Hochberg Massachusetts General Hospital
Xandra O. Breakefield
Xandra O. Breakefield Harvard University
Santosh Kesari
Santosh Kesari University of California, San Diego
Frank B. Furnari
Frank B. Furnari University of California, San Diego
Richard C. Mulligan
Richard C. Mulligan Harvard University
Anders M. Dale
Anders M. Dale J. Craig Venter Institute
William B. Isaacs
William B. Isaacs Johns Hopkins University
Linda M. Liau
Linda M. Liau University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring medical studies in the USA, there are several online degree and career pathways worth considering. Many students look for flexible options that allow them to advance their careers without disrupting their current schedules.

For registered nurses, rn bsn online programs no clinicals are a convenient choice, as they remove the need for additional clinical hours while still providing advanced knowledge. Licensed practical nurses can accelerate their progress with a 6 month lpn program online, making a career switch or advancement possible in less time.

For those aiming for a terminal nursing degree, options abound as well. If time is a concern, consider the shortest dnp programs, which allow you to earn a Doctor of Nursing Practice efficiently. Alternatively, choose from the easiest dnp programs if you're seeking a supportive learning environment with less stringent entry requirements.

These online pathways can open doors to advanced roles and specialized fields in healthcare, all while balancing work, life, and study.

Best Scientists Citing Bob S. Carter

Trending Scientists